未接受抗逆转录病毒治疗的HIV-2感染者中也存在少数耐药变异株
该研究纳入ANRS HIV-2 CO5队列中47例血浆病毒载量>100 copies/mL的未治疗HIV-2感染者,对蛋白酶、逆转录酶、整合酶和gp105区域进行超深度测序。1%阈值下PI、NRTI和整合酶抑制剂传播耐药率分别为13.2%、9.8%和4.5%,21%患者检出X4嗜性病毒。
要点
- 47例未治疗HIV-2感染者中,20%阈值下NRTI传播耐药率为7.9%。
- 1%阈值下PI、NRTI和整合酶抑制剂耐药率分别为13.2%、9.8%和4.5%。
- 21%患者检出X4嗜性病毒,其中2例为主要比例、2例为少数比例。
核心结论
- 这是首个评估未治疗HIV-2感染者中少数耐药变异株患病率的研究,使用1%突变检测阈值时耐药相关突变患病率较20%阈值高2-3倍。
- 使用超深度测序时,X4嗜性病毒患者比例也高出两倍。
研究设计与样本
- 纳入ANRS HIV-2 CO5队列中血浆病毒载量>100 copies/mL的未接受抗逆转录病毒治疗的HIV-2感染者。
- 对蛋白酶、逆转录酶、整合酶和gp105区域进行超深度测序,仅考虑HIV-2 ANRS列表中>1%的突变。
- 通过V3环区域超深度测序评估HIV-2嗜性,每条读长依据CXCR4辅助受体使用决定簇解读。
主要发现
- 47例患者中3例血浆病毒存在超过20%检测阈值的耐药相关突变,均位于逆转录酶,NRTI传播耐药患病率为7.9%(95%CI 0.0%-16.5%)。
- 蛋白酶或整合酶中未发现超过20%检测阈值的耐药相关突变。
- 1%检测阈值下,PI、NRTI和整合酶抑制剂的传播耐药患病率分别为13.2%(95%CI 3.5%-22.9%)、9.8%(95%CI 0.6%-19.0%)和4.5%(95%CI 0%-17.5%)。
- 最常见的少数耐药变异为PI耐药突变I50V,在3份样本中检出。
- 嗜性分析显示21%患者(19例中4例)存在X4嗜性病毒:2例为主要比例,2例为少数比例(1.5%和1.9%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the prevalence of minority resistant variants (MRV) and X4-tropic minority variants in ART-naive HIV-2-infected patients. PATIENTS AND METHODS: ART-naive HIV-2-infected patients with detectable plasma viral load (>100 copies/mL) included in the ANRS HIV-2 CO5 Cohort were assessed. We performed ultra-deep sequencing (UDS) of protease, RT, integrase and gp105 regions. Only mutations in the HIV-2 ANRS list >1% were considered. HIV-2 tropism was assessed by V3 loop region UDS, and each read was interpreted with determinants of CXCR4-coreceptor use. RESULTS: Among the 47 patients assessed, three displayed plasma viruses with a resistance-associated mutation (RAM) above the 20% detection threshold, all in RT, resulting in a prevalence of transmitted drug resistance for NRTI of 7.9% (95% CI 0.0%-16.5%). No RAM above the 20% detection threshold was found in protease or integrase. At the 1% detection threshold the transmitted drug resistance prevalence was 9.8% (95% CI 0.6%-19.0%), 13.2% (95% CI 3.5%-22.9%) and 4.5% (95% CI 0%-17.5%) for PI, NRTI and integrase inhibitors. The most prevalent MRV was the PI RAM I50V detected in three samples. Tropism analysis showed that 21% of patients (4 of 19) exhibited X4-tropic viruses: two in majority proportion and two in minority proportions (1.5% and 1.9%). CONCLUSIONS: In this first study assessing the prevalence of MRV in HIV-2 infection among ART-naive patients, we observed a 2-3-fold higher prevalence of RAM when a 1% detection threshold of mutations was used compared with a 20% threshold. Similarly, the proportion of patients with X4-tropic viruses was twice as high when UDS was used.
引用
- Storto A, Visseaux B, Bertine M, et al. Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients. J Antimicrob Chemother. 2018. PMID: 29415189. doi:10.1093/jac/dkx530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。